Industry Insights

31. Handling & Processing Of Potent Compounds: A Holistic Approach 5/5/2017

    The topic of potent compounds may seem obscure; however, it touches virtually every aspect of the biopharmaceutical business, from selection pressure in media to antibody-drug conjugates (ADCs). Every chemical and biological compound we work with has an MSDS (material safety data sheet) and an OEL (occupational exposure limit), which dictate how we must handle the compound and bring to the forefront issues of personnel safety and environmental impact that we must address in our manufacturing plants. When designing a process involving any potent compound, there are three aspects we must address directly: facilities, processing equipment, and people.

32. How To Optimize Your Fermentation Production 3/15/2023

    Check out adaptable and scalable single-use solutions and automated processes that improve efficiency, lower costs, and address human error and product loss in the pharmaceutical manufacturing process.

33. Green Gains In Biopharma Without Closing Facilities? 2/29/2024

    Going green is virtually impossible for biopharma companies with legacy systems, but going greener might be within reach. Here are some ideas to get started.

34. Seeing Double: Using Digital Twins To Improve Pharma Processes 12/30/2020

    The pairing of the virtual and physical worlds not only enables systems to be adapted or repaired from afar, but the approach also further enables the analysis of data and monitoring of systems to avoid problems before they even occur.

35. Opportunities For Implantable Drug Delivery To Modernize Drug Therapy 11/8/2021

    The implantable drug delivery system allows targeted and localized drug delivery for achieving an optimum therapeutic effect. This article examines the clinical significance of implantable drug delivery systems as well as opportunities that can be leveraged by drug therapy developers in meeting global health needs, particularly in the areas of women's health, cancer treatment, and ocular disease treatment.

36. The Roadmap To Outsourcing Vial Fill/Finish 1/16/2020

    Outsourcing a fill/finish project can be a challenging journey without a formal guide to the “right” path. Several key milestones along the way determine your outcome. This article will guide you through them.

37. Dynamic Trends Shaping The Future Of Microbial Fermentation 3/1/2024

    Drug developers must understand the latest trends in microbial fermentation. By leveraging innovative methods and technologies, developers can unlock new opportunities and improve patient outcomes.

38. What's The Difference When It Comes To Managing Quality? 8/27/2021

    QA and QC are not identical or interchangeable, but you’re likely to have peers who don’t understand the distinctions between them. Read this blog to help such individuals solve the mystery behind these frequently conflated quality functions.

39. Bacterial Endotoxin Testing, Part 1: Overview 7/16/2024

    All injectable drug products and implantable medical devices that come into contact with the bloodstream or spinal fluid are tested for endotoxins. This article provides an overview of bacterial endotoxin testing and the LAL method.

40. Demand More From Your Oligo Synthesizer 3/4/2024

    The market for oligonucleotide therapeutics is expanding, and the pipeline is diverse. Gain insight into how you can fast-track your molecule's development with verified synthesizers, columns, and scientific support and expertise.